Bosh sahifaBTL • FRA
add
Baxter International Inc
Yopilish kursi
16,41 €
Kunlik diapazon
16,05 € - 16,07 €
Yillik diapazon
14,99 € - 34,23 €
Bozor kapitalizatsiyasi
9,79 mlrd USD
Oʻrtacha hajm
4,00
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NYSE
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 2,97 mlrd | 8,03% |
Joriy xarajat | 741,00 mln | -13,13% |
Sof foyda | -1,13 mlrd | -120,31% |
Sof foyda marjasi | -37,93 | -103,92% |
Har bir ulushga tushum | 0,44 | -24,14% |
EBITDA | 459,00 mln | -10,87% |
Amaldagi soliq stavkasi | -36,90% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 1,97 mlrd | 11,45% |
Jami aktivlari | 20,06 mlrd | -22,21% |
Jami passivlari | 13,95 mlrd | -25,62% |
Umumiy kapital | 6,10 mlrd | — |
Tarqatilgan aksiyalar | 514,49 mln | — |
Narxi/balansdagi bahosi | 1,38 | — |
Aktivlardan daromad | 2,66% | — |
Kapitaldan daromad | 3,34% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -1,13 mlrd | -120,31% |
Operatsiyalardan naqd pul | 584,00 mln | 19,67% |
Sarmoyadan naqd pul | -198,00 mln | 3,41% |
Moliyadan naqd pul | -147,00 mln | -204,26% |
Naqd pulning sof oʻzgarishi | 240,00 mln | -28,14% |
Boʻsh pul | 397,75 mln | -32,04% |
Haqida
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois.
The company primarily focuses on products to treat chronic and acute medical conditions. The company had 2023 global net sales of $14.8 billion, across three business: "Medical Product and Therapies", "Healthcare Systems and Technologies" and Pharmaceuticals.
Baxter's Medical Product and Therapies business comprise two divisions: the first named "Advanced Surgery" that produce technologies to enhance surgeons' technique, increase efficiencies and improve outcomes. The second named "Infusion Therapies and Technologies" produces intravenous products and other products used in the delivery of fluids and drugs to patients.
Baxter's Healthcare System and Technologies business has four divisions "Front Line Care", "Digital Platform and Innovations", "Care and Connectivity Solutions" and "Global Services".
Baxter's Pharmaceuticals business produce inhalational anaesthetics and other differentiated hospital pharmaceuticals in areas of pain, critical care, anti-infection and oncology. Wikipedia
CEO
Tashkil etilgan
1931
Sayt
Xodimlar soni
37 500
